S 2416 117th Congress Senate Health Drug safety, medical device, and laboratory regulation Drug therapy Government information and archives Health care costs and insurance Health care coverage and access Health technology, devices, supplies Manufacturing Medicare Public participation and lobbying

NOVEL Act of 2021

Introduced: July 21, 2021 See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jul 21, 2021

Read twice and referred to the Committee on Finance.

Jul 21, 2021

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

New Opportunities for Value that Extend Lives Act of 2021 or the NOVEL Act of 2021

This bill establishes a process for expediting the assignment of Healthcare Common Procedure Coding System (HCPCS) codes to medical products that have been designated as a breakthrough product or regenerative advanced therapy by the Food and Drug Administration; it also establishes a process for determining coverage under Medicare of such breakthrough products that have been assigned HCPCS codes.

What's happening now July 21, 2021

Read twice and referred to the Committee on Finance.

Bill text 1 version